Presents the results of clinical trials on cytotoxic chemotherapeutic agents that have been undertaken to find an effective therapy for patients with metastatic androgen independent prostate cancer (AIPC). Role of cytotoxic chemotherapy in the treatment of PC; Factors that limit early trials on cytotoxic chemotherapeutic agents; Information on trials that show improved survival in AIPC using cytotoxic chemotherapy.